Regulation of mTORC1 by amino acids

The mechanistic target of rapamycin complex I (mTORC1) is a central regulator of cellular and organismal growth, and hyperactivation of this pathway is implicated in the pathogenesis of many human diseases including cancer and diabetes. mTORC1 promotes growth in response to the availability of nutri...

Full description

Bibliographic Details
Main Authors: Bar-Peled, Liron (Contributor), Sabatini, David (Contributor)
Other Authors: Massachusetts Institute of Technology. Department of Biology (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor)
Format: Article
Language:English
Published: Elsevier, 2017-06-30T17:59:37Z.
Subjects:
Online Access:Get fulltext
LEADER 01695 am a22002413u 4500
001 110392
042 |a dc 
100 1 0 |a Bar-Peled, Liron  |e author 
100 1 0 |a Massachusetts Institute of Technology. Department of Biology  |e contributor 
100 1 0 |a Koch Institute for Integrative Cancer Research at MIT  |e contributor 
100 1 0 |a Bar-Peled, Liron  |e contributor 
100 1 0 |a Sabatini, David  |e contributor 
700 1 0 |a Sabatini, David  |e author 
245 0 0 |a Regulation of mTORC1 by amino acids 
260 |b Elsevier,   |c 2017-06-30T17:59:37Z. 
856 |z Get fulltext  |u http://hdl.handle.net/1721.1/110392 
520 |a The mechanistic target of rapamycin complex I (mTORC1) is a central regulator of cellular and organismal growth, and hyperactivation of this pathway is implicated in the pathogenesis of many human diseases including cancer and diabetes. mTORC1 promotes growth in response to the availability of nutrients, such as amino acids, which drive mTORC1 to the lysosomal surface, its site of activation. How amino acid levels are communicated to mTORC1 is only recently coming to light by the discovery of a lysosome-based signaling system composed of Rags (Ras-related GTPases) and Ragulator v-ATPase, GATOR (GAP activity towards Rags), and folliculin (FLCN) complexes. Increased understanding of this pathway will not only provide insight into growth control but also into the human pathologies triggered by its deregulation. 
520 |a National Institutes of Health (U.S.) (CA103866) 
520 |a National Institutes of Health (U.S.) (AI473890 
520 |a United States. Department of Defense (W81XWH-07-0448) 
546 |a en_US 
655 7 |a Article 
773 |t Trends in Cell Biology